TrialHepatology communications2026

Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.

Stuart C Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.